Synopsys, Inc. (SNPS) Shares Bought by American Century Companies Inc.
American Century Companies Inc. increased its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS) by 3.2% in the fourth quarter, HoldingsChannel.com reports. The firm owned 362,471 shares of the semiconductor company’s stock after buying an additional 11,084 shares during the period. American Century Companies Inc.’s holdings in Synopsys were worth $30,897,000 as of its most recent filing with the SEC.
Other institutional investors have also bought and sold shares of the company. Cerebellum GP LLC bought a new position in Synopsys during the fourth quarter worth about $124,000. Conning Inc. bought a new position in Synopsys during the fourth quarter worth about $205,000. Checchi Capital Advisers LLC bought a new position in Synopsys during the fourth quarter worth about $205,000. Advisor Partners LLC bought a new position in Synopsys during the fourth quarter worth about $233,000. Finally, Advisor Group Inc. grew its holdings in Synopsys by 14.3% during the second quarter. Advisor Group Inc. now owns 2,617 shares of the semiconductor company’s stock worth $190,000 after purchasing an additional 327 shares during the period. Institutional investors and hedge funds own 89.77% of the company’s stock.
Shares of Synopsys, Inc. (SNPS) opened at $85.50 on Wednesday. Synopsys, Inc. has a 1-year low of $65.31 and a 1-year high of $94.80. The stock has a market capitalization of $12,720.00, a P/E ratio of 99.42, a PEG ratio of 3.76 and a beta of 1.04. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.04.
In other news, CEO Chi-Foon Chan sold 3,750 shares of the business’s stock in a transaction that occurred on Friday, December 1st. The stock was sold at an average price of $89.78, for a total transaction of $336,675.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Steven Walske sold 4,545 shares of the business’s stock in a transaction that occurred on Wednesday, January 17th. The stock was sold at an average price of $90.12, for a total value of $409,595.40. Following the sale, the director now owns 14,988 shares of the company’s stock, valued at approximately $1,350,718.56. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 65,442 shares of company stock valued at $5,779,693. Corporate insiders own 1.82% of the company’s stock.
A number of equities analysts recently commented on SNPS shares. Needham & Company LLC lifted their price target on Synopsys from $83.00 to $100.00 and gave the stock a “buy” rating in a report on Friday, December 1st. Royal Bank of Canada reiterated a “buy” rating and set a $120.00 price target on shares of Synopsys in a report on Thursday, November 30th. BidaskClub upgraded Synopsys from a “hold” rating to a “buy” rating in a report on Tuesday, January 23rd. DA Davidson reiterated a “buy” rating and set a $105.00 price target (up previously from $91.00) on shares of Synopsys in a report on Tuesday, November 28th. Finally, TheStreet cut Synopsys from an “a” rating to a “c+” rating in a report on Wednesday, November 29th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and seven have given a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus price target of $96.89.
Synopsys Company Profile
Synopsys, Inc provides software, intellectual property (IP) and services. The Company supplies the electronic design automation (EDA) software that engineers use to design and test integrated circuits, also known as chips. It also offers IP products, which are pre-designed circuits that engineers use as components of larger chip designs rather than designing those circuits themselves.
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.